Clinical Trials Logo

Filter by:
NCT ID: NCT03352206 Completed - Clinical trials for Lymphatic Filariases

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

Start date: October 18, 2017
Phase:
Study type: Observational

This study will assess the impact of 2-drug (DA) or 3-drug (IDA) regimens on lymphatic filariasis infection parameters in communities. Parameters measured will include: circulating filarial antigenemia (CFA) assessed with the Filariasis Test Strip (FTS), antifilarial antibodies tested with plasma and microfilaremia (assessed by night blood smears and microscopy).

NCT ID: NCT03343145 Completed - Breast Cancer Clinical Trials

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Start date: January 12, 2017
Phase: Phase 3
Study type: Interventional

A study to compare the efficacy, safety and immunogenicity of Leucostim® to those of Neupogen® in patients with breast cancer intended to be treated with TAC regimen as a myelosuppressive chemotherapy.

NCT ID: NCT03336593 Completed - Safety Issues Clinical Trials

Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

Start date: November 21, 2017
Phase: Phase 2
Study type: Interventional

This study is to assess protectivity and safety of Quadrivalent Influenza Vaccine in Indonesian Population

NCT ID: NCT03333473 Completed - Clinical trials for Post-pregnancy Family Planning

Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia

PPFP Choices
Start date: November 9, 2017
Phase: N/A
Study type: Interventional

The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private-for-profit sectors. The ultimate intent of this investment is to advance and scale up post-pregnancy FP. Programmatic learning will be crucial to understanding what it will take to accelerate post-pregnancy FP in these two countries, and these can later be adapted by other countries with similar settings. Our vision of PPFP Choices can be achieved through the following objectives: - Objective 1: Establish a comprehensive program implementation framework for the private sector to embrace post-pregnancy FP - Objective 2: Improve the quality of post-pregnancy FP counseling and service provision in both public and private sectors - Objective 3: Build evidence and contribute to the literature and programmatic guidance around post-pregnancy FP uptake and continuation in both public and private sectors - Objective 4: Ensure effective documentation and strategic dissemination which will benefit post-pregnancy FP introduction and scale-up more broadly

NCT ID: NCT03321383 Completed - Dyspepsia Clinical Trials

Health Related Quality of Life in Functional Dyspepsia

Start date: August 1, 2016
Phase: N/A
Study type: Observational

Previous studies reported health related quality of life impairment in functional dyspepsia patients. Anxiety, depression, disease severity, age, and employment status associated with HRQOL in functional dyspepsia patients. However, data about HRQOL in Asian population was limited.This study aimed to evaluate factors associated with health related quality of life in patients with functional dyspepsia.

NCT ID: NCT03310450 Completed - Oxidative Stress Clinical Trials

Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels

TdBTS
Start date: October 28, 2017
Phase:
Study type: Observational

Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017

NCT ID: NCT03310073 Completed - Healthy Clinical Trials

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Start date: July 2016
Phase: Phase 4
Study type: Interventional

This study is to assess protectivity following four doses of bOPV which given simultaneously with Pentabio® and 1 dose of IPV at the 4th visit

NCT ID: NCT03292744 Recruiting - Clinical trials for Frail Elderly Syndrome

Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly

Start date: January 10, 2017
Phase: Phase 4
Study type: Interventional

Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In elderly, immune disregulation or immunosenecence have great impact to infection response. This study is aimed to determine the effect of alfacalcidol supplementation in vitro and in vivo to respiratory infection incidence and inflammatory markers, as well as T cell lymphocyte subset in Indonesian elderly patients.

NCT ID: NCT03279900 Completed - Acute Leukemia Clinical Trials

Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy

Start date: October 2, 2017
Phase:
Study type: Observational

This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.

NCT ID: NCT03273387 Completed - Clinical trials for Precapillary Pulmonary Hypertension

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension

TRIMETA-PH
Start date: September 10, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The study will evaluate the effect of trimetazidine versus placebo in addition to standard pulmonary arterial hypertension regime on right ventricular function in pulmonary arterial hypertension patients.